CVWF as a Biomarker in TTP and Neurobiological Mechanisms of Pain in SCD Patients

The chapter explores CVWF as a potential biomarker in thrombotic diseases like TTP, highlighting its correlation with plasmin activation and implications for thrombotic microangiopathy. It also delves into a study on the neurobiological mechanisms of pain in SCD patients, emphasizing the need for non-opioid therapies to manage severe recurrent pain.